News
The wearable uses its motion sensors to determine if the user has taken a hard fall and can contact emergency services if they don't respond.
The mental health platform let go of 15% of its workforce.
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
The company reported $526.9 million in revenue last year compared with $271.9 million in 2021.
Rock Health’s 2022 Digital Health Consumer Adoption Survey also found non-video telehealth offerings have become more popular.
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
A Pew Research Center survey of more than 11,000 U.S. adults reveals the majority would feel uncomfortable if their healthcare provider relied on AI for their care.
The organizations said Medicare Advantage members in 24 counties will have access to the rural provider's services.
Users will have access to symptom tracking and educational content, while its enterprise customers can obtain additional on-demand coaching and support.